Ubs Group Ag Biora Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 10, 2022	SELL	$0.53 - $13.3 $537 - $13,499	-1,015 Reduced 99.9%	1 $0
Q2 2022 Aug 10, 2022	BUY	$0.56 - $1.22 $568 - $1,239	1,016 New	1,016 $1,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $4.89 $20,873 - $75,609	-15,462 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.67 - $3.41 $5,863 - $29,840	8,751 Added 130.4%	15,462 $24,000
Q2 2021 Aug 13, 2021	SELL	$2.11 - $4.93 $14,371 - $33,578	-6,811 Reduced 50.37%	6,711 $24,000
Q1 2021 May 12, 2021	SELL	$3.91 - $7.31 $8,363 - $15,636	-2,139 Reduced 13.66%	13,522 $65,000
Q4 2020 Feb 11, 2021	BUY	$3.27 - $9.48 $45,246 - $131,174	13,837 Added 758.61%	15,661 $84,000
Q3 2020 Nov 12, 2020	BUY	$7.71 - $10.79 $14,063 - $19,680	1,824 New	1,824 $16,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $41.1M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.